134 research outputs found
Talking Ethics Early in Health Data Public Private Partnerships
Data access and data sharing are vital to advance medicine. A growing number of public private partnerships are set up to facilitate data access and sharing, as private and public actors possess highly complementary health data sets and treatment development resources. However, the priorities and incentives of public and private organizations are frequently in conflict. This has complicated partnerships and sparked public concerns around ethical issues such as trust, justice or privacyâin turn raising an important problem in business and data ethics: how can ethical theory inform the practice of public and private partners to mitigate misaligned incentives, and ensure that they can deliver societally beneficial innovation? In this paper, we report on the development of the Swiss Personalized Health Networkâs ethical guidelines for health data sharing in public private partnerships. We describe the process of identifying ethical issues and engaging core stakeholders to incorporate their practical reality on these issues. Our report highlights core ethical issues in health data public private partnerships and provides strategies for how to overcome these in the Swiss health data context. By agreeing on and formalizing ethical principles and practices at the beginning of a partnership, partners and society can benefit from a relationship built around a mutual commitment to ethical principles. We present this summary in the hope that it will contribute to the global data sharing dialogue
Ethics of Artificial Intelligence Demarcations
In this paper we present a set of key demarcations, particularly important
when discussing ethical and societal issues of current AI research and
applications. Properly distinguishing issues and concerns related to Artificial
General Intelligence and weak AI, between symbolic and connectionist AI, AI
methods, data and applications are prerequisites for an informed debate. Such
demarcations would not only facilitate much-needed discussions on ethics on
current AI technologies and research. In addition sufficiently establishing
such demarcations would also enhance knowledge-sharing and support rigor in
interdisciplinary research between technical and social sciences.Comment: Proceedings of the Norwegian AI Symposium 2019 (NAIS 2019),
Trondheim, Norwa
Public preferences towards data management and governance in Swiss biobanks: results from a nationwide survey.
OBJECTIVES
This article aims to measure the willingness of the Swiss public to participate in personalised health research, and their preferences regarding data management and governance.
SETTING
Results are presented from a nationwide survey of members of the Swiss public.
PARTICIPANTS
15â106 randomly selected Swiss residents received the survey in September 2019. The response rate was 34.1% (n=5156). Respondent age ranged from 18 to 79 years, with fairly uniform spread across sex and age categories between 25 and 64 years.
PRIMARY AND SECONDARY OUTCOME MEASURES
Willingness to participate in personalised health research and opinions regarding data management and governance.
RESULTS
Most respondents preferred to be contacted and reconsented for each new project using their data (39%, 95%âCI: 37.4% to 40.7%), or stated that their preference depends on the project type (29.4%, 95%âCI: 27.9% to 31%). Additionally, a majority (52%, 95%âCI: 50.3% to 53.8%) preferred their data or samples be stored anonymously or in coded form (43.4%, 95%âCI: 41.7% to 45.1%). Of those who preferred that their data be anonymised, most also indicated a wish to be recontacted for each new project (36.8%, 95%âCI: 34.5% to 39.2%); however, these preferences are in conflict. Most respondents desired to personally own their data. Finally, most Swiss respondents trust their doctors, along with researchers at universities, to protect their data.
CONCLUSION
Insight into public preference can enable Swiss biobanks and research institutions to create management and governance strategies that match the expectations and preferences of potential participants. Models allowing participants to choose how to interact with the process, while more complex, may increase individual willingness to provide data to biobanks
âMeet Me Halfway,â Said the Robot to the Regulation:Linking Ex-Ante Technology Impact Assessments to Legislative Ex-Post Evaluations via Shared Data Repositories for Robot Governance
Trust, morality and altruism in the donation of biological material : the case of Portugal
This paper examines a number of social, ethical and cultural issues related to the
application of biotechnology. The focus of the paper relies on two different cases
of governing biotechnology in Portugal, referring to donation of biological
material: the act of donation of eggs and sperm; and volunteers for donation of
DNA material for the forensic national DNA database. We analyze the
discourses on donation of biological material framing them in rhetorical
devices of gift, altruism, informed consent and social responsibility. This comes
blended with still unclear and emergent regulation and policies of access,
retention, preservation and governing of biological material and of donorsâ
identification. The risks are mitigated by narratives of science and technology
as social progress and providers of public good and health benefits, as well as
by underlining the individual responsibility in this domain and by reinforcing
the rhetoric of gene quality, based on socio-cultural and bio-genetic criteria
Digital orphans: Data closure and openness in patient- powered networks
This is the author accepted manuscript. The final version is available from Palgrave Macmillan via the DOI in this record.In this paper, we discuss an issue linked to data-sharing regimes in patient-powered, social-media-based networks, namely that most of the data that patient users share are not used to research scientific issues or the patient voice. This is not a trivial issue, as participation in these networks is linked to openness in data sharing, which would benefits fellow patients and contributes to the public good more generally. Patient-powered research networks are often framed as disrupting research agendas and the industry. However, when data that patients share are not accessible for research, their epistemic potential is denied. The problem is linked to the business models of the organisations managing these networks: models centred on controlling patient data tend to close networks with regard to data use. The constraint on research is at odds with the ideals of a sharing, open and supportive epistemic community that networksâ own narratives evoke. This kind of failure can create peculiar scenarios, such as the emergence of the âdigital orphansâ of Internet research. By pointing out the issue of data use, this paper informs the discussion about the capacity of patient-powered networks to support research participation and the patient voice.We are indebted to the anonymous reviewers and the editor, who with their supportive and constructive comments helped us to better clarify and highlight the argument of the article. We would like to also thank friends and colleagues who have offered valuable comments and suggestions on early drafts of this paper. We would like to especially thank Barbara Prainsack, Sabina Leonelli, Alena Buyx, and David Teira. This research is funded by the European Research Council (ERC) under the European Unionâs Seventh Framework Programme (FP7/2007â2013)/ERC grant agreement number 335925, and the German Federal Ministry of Education and Research (grant number 01GP1311
Posthumous Medical Data Donation: The Case for a Legal Framework
This article explores the options for establishing a legal framework for posthumous medical data donation (PMDD). This concept has not been discussed in legal scholarship to date at all. The paper is, therefore, a first legal study of PMDD, aiming to address the gap and shed light on the most significant legal issues that could affect this concept. The paper starts by looking at the protection of the deceasedâs health records and medical data, finding that this protection in law is more extensive than the general protection of the deceasedâs personal data, or the protection of post-mortem privacy as a concept. The paper then investigates key issues around ownership and succession of personal data, including medical and health-related data, and how these could affect PMDD and its legal framework. The author then goes on to explore some parallels with organ donation to determine whether there are some lessons to be learned from this comparable regulatory framework. The paper concludes with the discussion around the need for a Code for posthumous medical data donation developed by the Digital Ethics Lab at the Oxford Internet Institute, and a more formal regime that would enable and facilitate this practice. Here, the author proposes key law reforms in the area of data protection and governance related to PMDD. These reforms would include amendments to the general data protection ideally, to ensure harmonisation and consistency across the EU, as well as between the general and sector-specific data protection laws and policies. These changes would contribute to legal and regulatory clarity and would help implement this important and valuable practice, which aims to facilitate research and advances in medical treatments and care
The ethics of uncertainty for data subjects
Modern health data practices come with many practical uncertainties. In this paper, I argue that data subjectsâ trust in the institutions and organizations that control their data, and their ability to know their own moral obligations in relation to their data, are undermined by significant uncertainties regarding the what, how, and who of mass data collection and analysis. I conclude by considering how proposals for managing situations of high uncertainty might be applied to this problem. These emphasize increasing organizational flexibility, knowledge, and capacity, and reducing hazard
- âŠ